Biotech RadarJobs updated

COMPANY

Clinuvel Pharmaceuticals

HQ: San Mateo, CA (US office) source · clinuvel.com ↗

Clinical Phase 3

Location: San Mateo, CA (US office) · source · Oct 15, 2026

Profile checked Oct 10, 2026

Keywords: Vitiligo Afamelanotide

2Trials (company is sponsor)

Timeline

  1. Trial start Phase 3: A Study to Compare the Efficacy and Safety of SCENESSE and Narrow-Band Ultraviolet (NB-UVB) Light Versus NB-UVB Light Alone in Patients With Vitiligo source ↗
  2. Trial start Phase 2: A Study to Assess the Changes in Pigmentation and Safety of Afamelanotide in Patients With Vitiligo on the Face source ↗

Clinical trials (lead sponsor) 2

RecordTitlePhaseStatusStartPrimary completion
NCT06109649A Study to Compare the Efficacy and Safety of SCENESSE and Narrow-Band Ultraviolet (NB-UVB) Light Versus NB-UVB Light Alone in Patients With VitiligoPhase 3Active, not recruitingOct 11, 20232025-12 (estimated)
NCT05210582A Study to Assess the Changes in Pigmentation and Safety of Afamelanotide in Patients With Vitiligo on the FacePhase 2Unknown status (ClinicalTrials.gov)Oct 11, 20222023-04 (estimated)
Feedback